The producer of image recognition technology stemmed from Chinese University of Hong Kong’s Media Lab has gone public in Hong Kong as the Chinese government introduces new regulations governing foreign IPOs.
A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
The Ohio State spinout has gone public in an upsized IPO sized at approximately $182m.
Having priced its shares at the top of its range, UChicago spinout Pyxis Oncology suffered a drop on the first day of trading.
The cancer drug developer has closed its initial public offering after underwriters exercised the greenshoe option.
UChicago spinout Pyxis Oncology is aiming to raise more than $153m in its initial public offering, having set a price range of $14 to $16.
The Dundee spinout has raised more than $304m in its IPO in the US, with another $160m secured through a concurrent private placement.
Based on research at Deakin University, Li-S Energy has gone public on the Australian Stock Exchange after raising $25m in its initial public offering.
Case Western Reserve University-linked Lucid Diagnostics is seeking an initial public offering that would net it up to $57.5m.
Oracle has signed up to be a cornerstone investor for Oxford Nanopore’s initial public offering, putting up half of the $410m target.
Based on research at Drexel University, Context Therapeutics is seeking to raise up to $21m in an initial public offering on Nasdaq.
Dundee spinout Exscientia is continuing a busy fundraising year with a filing for an IPO in the US and a $35m concurrent private placement.
UW's vaccine development company has listed on Nasdaq, with its shares rising on the first day of trading.
Corporate-backed artificial intelligence technology developer SenseTime has set terms for an offering which could illustrate where China's troubled public markets space currently lies.
The Access Industries and Grupo Wiese-backed workspace and short-term accommodation service is merging with BOA Acquisition Corp in a reverse takeover at a valuation of about $1.2bn.
Citi Ventures-backed Braze priced the offering above its range and it valued the customer engagement software producer at almost $5.9bn.
The Alibaba, Ant Group, Berkshire Hathaway, Intel and SoftBank-backed e-commerce payment app operator is set to list on the NSE and BSE next week at a potential valuation of up to $18.7bn.